WallStreetZenWallStreetZen

NASDAQ: XXII
22nd Century Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their XXII stock forecasts and price targets.

Forecast return on equity

Is XXII forecast to generate an efficient return?

Company
N/A
Industry
-178.38%
Market
79.49%

Forecast return on assets

Is XXII forecast to generate an efficient return on assets?

Company
N/A
Industry
24.57%

XXII earnings per share forecast

What is XXII's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.33
Avg 2 year Forecast
$1.06

XXII revenue forecast

What is XXII's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$28.5M+16.81%
Avg 2 year Forecast
$51.7M+112.04%
Avg 3 year Forecast
$71.9M+194.77%
XXII's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XXII revenue growth forecast

How is XXII forecast to perform vs Tobacco companies and vs the US market?

Company
43.72%
Industry
4.1%
Market
9.66%
XXII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XXII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XXII vs Tobacco Stocks

TickerPricePrice TargetUp/downsideConsensus
XXII$1.25N/AN/A
GNLN$0.01N/AN/A
KAVL$0.60N/AN/A
ISPR$2.90$9.00+210.34%Strong Buy
TPB$75.66$73.75-2.52%Strong Buy
View Top Tobacco Stocks

22nd Century Group Stock Forecast FAQ

What is XXII's earnings growth forecast for 2025-2026?

(NASDAQ: XXII) 22nd Century Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Tobacco industry's average forecast earnings growth rate of 16.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.83%.

22nd Century Group's earnings in 2025 is -$25,467,000.On average, 1 Wall Street analyst forecast XXII's earnings for 2025 to be -$5,521,056, with the lowest XXII earnings forecast at -$5,521,056, and the highest XXII earnings forecast at -$5,521,056.

In 2026, XXII is forecast to generate $2,511,725 in earnings, with the lowest earnings forecast at $2,511,725 and the highest earnings forecast at $2,511,725.

If you're new to stock investing, here's how to buy 22nd Century Group stock.

What is XXII's revenue growth forecast for 2025-2027?

(NASDAQ: XXII) 22nd Century Group's forecast annual revenue growth rate of 43.72% is forecast to beat the US Tobacco industry's average forecast revenue growth rate of 4.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.66%.

22nd Century Group's revenue in 2025 is $24,382,000.On average, 1 Wall Street analysts forecast XXII's revenue for 2025 to be $67,484,841, with the lowest XXII revenue forecast at $67,484,841, and the highest XXII revenue forecast at $67,484,841. On average, 1 Wall Street analysts forecast XXII's revenue for 2026 to be $122,505,838, with the lowest XXII revenue forecast at $122,505,838, and the highest XXII revenue forecast at $122,505,838.

In 2027, XXII is forecast to generate $170,299,702 in revenue, with the lowest revenue forecast at $170,299,702 and the highest revenue forecast at $170,299,702.

What is XXII's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: XXII) forecast ROA is N/A, which is lower than the forecast US Tobacco industry average of 24.57%.

What is XXII's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: XXII) 22nd Century Group's current Earnings Per Share (EPS) is -$173.97. On average, analysts forecast that XXII's EPS will be -$2.33 for 2025, with the lowest EPS forecast at -$2.33, and the highest EPS forecast at -$2.33. In 2026, XXII's EPS is forecast to hit $1.06 (min: $1.06, max: $1.06).

What is XXII's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: XXII) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.